Abstract |
This paper contains a brief review of the metabolism and physiological actions of eicosanoids, with a discussion of the potential clinical implications of disturbances in eicosanoid metabolism, particularly in NSAID-induced upper gastrointestinal damage and inflammatory bowel disease. There follows a summary of current evidence for the role of eicosanoids in the pathogenesis of colorectal neoplasia.
|
Authors | G R Davies, D S Rampton |
Journal | European journal of gastroenterology & hepatology
(Eur J Gastroenterol Hepatol)
Vol. 9
Issue 11
Pg. 1033-44
(Nov 1997)
ISSN: 0954-691X [Print] England |
PMID | 9431891
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase Inhibitors
- Eicosanoids
- Prostaglandin Antagonists
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(adverse effects, pharmacology)
- Colonic Neoplasms
(prevention & control)
- Colonic Polyps
(prevention & control)
- Colorectal Neoplasms
(physiopathology)
- Cyclooxygenase Inhibitors
(pharmacology)
- Eicosanoids
(metabolism, physiology)
- Gastrointestinal Diseases
(drug therapy, immunology, physiopathology)
- Humans
- Inflammation
(physiopathology)
- Inflammatory Bowel Diseases
(physiopathology)
- Peptic Ulcer
(chemically induced, drug therapy, prevention & control)
- Prostaglandin Antagonists
(pharmacology)
|